Department Head: Ilona Kopyta, MD. Ph.D.

Head Nurse: Urszula Rola, MA

Secretary’s office of the Department: (32) 207 16 00

email: neurologia@gczd.katowice.pl

Number of beds: 43; 17 beds for small children up to 3 years of age and 26 beds for older children, aged 3- 18

Floor: 7

 

The Department provides diagnostics and treatment of the following diseases:

  • epilepsy, in particular drug-resistant epilepsy
  • non-epileptic paroxysmal states
  • inflammatory and demyelinating diseases of the central and peripheral nervous system
  • neuromuscular diseases
  • cerebrovascular diseases
  • neurodevelopmental disorders, including autism spectrum disorders
  • infantile cerebral palsy
  • progressive encephalopathy
  • inborn defects of metabolism
  • headaches

 

In the case of children suffering from drug-resistant epilepsy we provide complete diagnostics and pharmacological and dietary treatment (ketogenic diet), while in cooperation with a team of neurosurgeons we qualify patients for surgical treatment.

In the case of patients with spasticity we apply botulinum toxin therapy and we qualify patients for intrathecal baclofen therapy with the use of baclofen pump.

 

 

 

The Department offers two therapeutic programmes financed by the National Health Fund:

  • Treatment of spasticity in children with infantile cerebral palsy with botulinum toxin.

Patients with diagnosed infantile cerebral palsy (confirmed by additional examinations) are qualified for botulinum toxin therapy by a medical team consisting of a neurologist and physiotherapist. Administration of the drug takes place in the Department and is preceded by local anaesthesia. The child is discharged home a few hours after the drug administration if their health condition is satisfactory.

  • Immunomodulatory treatment of patients with multiple sclerosis.

only patients who meet the criteria specified by the National Health Fund are qualified for the programme. In compliance with the programme, further check-ups need to take place in the Department where the necessary examinations and treatment are performed.

The department’s medical personnel has long-standing experience in the management of patients under these above-mentioned therapeutic programmes. The treatment is burdened with minor side effects and the results are satisfactory.

Each year we also refer patients undergoing immunomodulatory treatment to centres for adults where further medical care is continued.

 

Laboratories:

  • EEG Laboratory

The laboratory allows one to conduct examinations during wakefulness or spontaneous sleep with the application of photostimulation and hyperventilation, and to record the examination on video. Furthermore, in some cases we can conduct 24-hour Holter EEG monitoring.

  • EMG Laboratory

The laboratory conducts examinations of peripheral and central nerves, e.g. in the case of facial nerve paralysis. Examination of the muscles (electromyography) is performed in patients with suspected neuromuscular disorders, including metabolic disorders. In exceptional circumstances (suspicion of myasthenia gravis) an electrophysiological myasthenic test is performed.

  • Ultrasound Laboratory

The laboratory is equipped with a device for transfontanelle ultrasonography, which enables one to examine selected sections of the large vessels using the Duplex method.

  • Rehabilitation Laboratory

The laboratory provides services in the scope of general physical rehabilitation and pulmonary rehabilitation.

  • Psychological Laboratory

The laboratory conducts examinations to asses the current level of development of children as well as examination aimed at evaluation of emotional disorders and identification of reasons for learning difficulties. In particular cases it is possible to seek the opinion of a child psychiatrist.